A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy

Author(s):
Victor, R.G.; Sweeney, H.L.; Finkel, R.; McDonald, C.M.; Byrne, B.; Eagle, M.; Goemans, N.; Vandenborne, K.; Dubrovsky, A.L.; Topaloglu, H.; Miceli, M.C.; Furlong, P.; Landry, J.; Elashoff, R.; Cox, D.; Tadalafil DMD Study Grp
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-24
Language
English
Is part of
Neurology (2017), Vol. 89, no. 17, p. 1811-1820
hdl
1887/115132
doi
10.1212/WNL.0000000000004570